ITI Pharma and Healthcare Fund Regular vs Tata India Pharma & Healthcare Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹1296 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.35 | 2.14 |
| Manager | Rohan Korde | Meeta Shetty |
| ISIN Code | INF00XX01BL5 | INF277K016A9 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -1.27% | -0.42% |
| 6 Month | 4.64% | 7.15% |
| 1 Year | -3.18% | 1.77% |
| 3 Year | 18.88% | 21.91% |
| 5 Year | - | 17.97% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | 0.5% | 1.48% |
| 1 Year | 2.76% | 7.11% |
| 3 Year | 16.71% | 19.19% |
| 5 Year | - | 17.54% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 18.94% | 8.89% |
| 3 Year | 20.21% | 18.72% |
| 5 Year | - | 15.51% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 15.64% | 16.04% |
| Sharp | 0.77% | 0.90% |
| Beta | 0.95% | 0.97% |
| Alpha | -2.74% | -0.83% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Rohan Korde | Meeta Shetty |
| Total AUM | ₹4626 Cr | ₹17847 Cr |
| Funds Managed | 10 | 5 |
| ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 3.56 | 4.14 |
| Large Cap | 29.45 | 25.14 |
| Mid Cap | 37.33 | 37.44 |
| Small Cap | 29.66 | 33.28 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.52 | 1.72 |
| Healthcare | 91.78 | 94.07 |
| Basic Materials | 3.67 | 2.64 |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | 1.58 |
Top Comparisons
HDFC Banking and Financial Services Fund - Growth Option
3Y Returns16.12%
Sundaram Financial Services Opportunities Fund Regular Plan - Growth
3Y Returns17.81%
Franklin U.S. Opportunities Equity Active FOF - Regular - Growth
3Y Returns23.78%
PGIM India Global Equity Opportunities Fund of Fund - Growth
3Y Returns23.17%
Kotak Debt Hybrid - Growth
3Y Returns10%
DSP Regular Savings Fund- Regular Plan - Growth
3Y Returns10%
Aditya Birla Sun Life Corporate Bond Fund - Growth - Regular Plan
3Y Returns7.91%
Mirae Asset Corporate Bond Fund Regular Growth
3Y Returns7.36%